{
  "ticker": "ARTV",
  "name": "Artiva Biotherapeutics, Inc.",
  "quarters": [
    {
      "date": "2023-06-30T00:00:00",
      "quarter_label": "2023-06 (Q2)",
      "revenue": 3497000,
      "gross_profit": null,
      "operating_income": -11824000,
      "net_income": -11284000,
      "opex": 15321000,
      "cogs": null,
      "rd": 11262000,
      "sga": null,
      "fcf": null,
      "ocf": null,
      "capex": null,
      "gross_margin": null,
      "op_margin": -3.3811838718901917,
      "fcf_margin": null
    },
    {
      "date": "2023-09-30T00:00:00",
      "quarter_label": "2023-09 (Q3)",
      "revenue": 26656000,
      "gross_profit": null,
      "operating_income": 10811000,
      "net_income": 11279000,
      "opex": 15845000,
      "cogs": null,
      "rd": 13065000,
      "sga": null,
      "fcf": -10927000,
      "ocf": -10748000,
      "capex": -179000,
      "gross_margin": null,
      "op_margin": 0.4055747298919568,
      "fcf_margin": -0.4099264705882353,
      "op_leverage_ratio": 193.63327726928424
    },
    {
      "date": "2023-12-31T00:00:00",
      "quarter_label": "2023-12 (Q4)",
      "revenue": 2350000,
      "gross_profit": null,
      "operating_income": -11970000,
      "net_income": -11998000,
      "opex": 14320000,
      "cogs": null,
      "rd": 11153000,
      "sga": null,
      "fcf": -11311000,
      "ocf": -10675000,
      "capex": -636000,
      "gross_margin": null,
      "op_margin": -5.093617021276596,
      "fcf_margin": -4.813191489361702,
      "fcf_margin_change": -4.4032650187734665
    },
    {
      "date": "2024-03-31T00:00:00",
      "quarter_label": "2024-03 (Q1)",
      "revenue": 251000,
      "gross_profit": null,
      "operating_income": -14492000,
      "net_income": -13963000,
      "opex": 14743000,
      "cogs": null,
      "rd": 11156000,
      "sga": null,
      "fcf": -15104000,
      "ocf": -15086000,
      "capex": -18000,
      "gross_margin": null,
      "op_margin": -57.73705179282869,
      "fcf_margin": -60.17529880478088,
      "fcf_margin_change": -55.36210731541918
    },
    {
      "date": "2024-12-31T00:00:00",
      "quarter_label": "2024-12 (Q4)",
      "revenue": 0,
      "gross_profit": null,
      "operating_income": -18267000,
      "net_income": -16095000,
      "opex": 18267000,
      "cogs": null,
      "rd": 13317000,
      "sga": null,
      "fcf": -14714000,
      "ocf": -14650000,
      "capex": -64000,
      "gross_margin": null,
      "op_margin": null,
      "fcf_margin": null,
      "incr_op_margin_yoy": 2.6795744680851064,
      "rev_growth_yoy": -1.0
    }
  ],
  "signals": [
    {
      "quarter": "2023-09 (Q3)",
      "signal": "OPERATING LEVERAGE",
      "detail": "Rev growth +662.3% vs OpEx growth +3.4% (leverage: 193.6x)",
      "severity": "MEDIUM"
    },
    {
      "quarter": "2023-09 (Q3)",
      "signal": "OP MARGIN TURNED POSITIVE (QoQ)",
      "detail": "Op margin: -338.1% -> +40.6%",
      "severity": "HIGH"
    }
  ],
  "data_quality": {
    "n_quarters": 5,
    "coverage": {
      "revenue": [
        5,
        5
      ],
      "gross_profit": [
        0,
        5
      ],
      "op_income": [
        5,
        5
      ],
      "fcf": [
        4,
        5
      ]
    },
    "gaps": [
      [
        "2024-03 (Q1)",
        "2024-12 (Q4)",
        275
      ]
    ],
    "warnings": [
      "gross_profit: no data",
      "gap: 2Q missing between 2024-03 (Q1) and 2024-12 (Q4)"
    ]
  },
  "market_cap": null,
  "source": "SEC EDGAR",
  "last_updated": "2026-02-02T23:16:32.975597"
}